. . . . . . . . . . . "a(CHEBI:androgen) -| r(HGNC:BCL2)" . "Approximately 61,000 statements." . "Copyright (c) 2011-2012, Selventa. All rights reserved." . "BEL Framework Large Corpus Document" . . "1.4" . "The oncogene Bcl-2 is upregulated frequently in prostate tumors following androgen ablation therapy, and Bcl-2 overexpression may contribute to the androgen-refractory relapse of the disease." . . "Selventa" . . . . "2014-07-03T14:30:19.019+02:00"^^ . . .